These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1486071)

  • 1. Topical ofloxacin compared with gentamicin in the treatment of external ocular infection. Ofloxacin Study Group.
    Gwon A
    Br J Ophthalmol; 1992 Dec; 76(12):714-8. PubMed ID: 1486071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topically administered norfloxacin compared with topically administered gentamicin for the treatment of external ocular bacterial infections. The Worldwide Norfloxacin Ophthalmic Study Group.
    Miller IM; Vogel R; Cook TJ; Wittreich J
    Am J Ophthalmol; 1992 Jun; 113(6):638-44. PubMed ID: 1598954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ofloxacin compared with chloramphenicol in the management of external ocular infection.
    Bron AJ; Leber G; Rizk SN; Baig H; Elkington AR; Kirkby GR; Neoh C; Harden A; Leong T
    Br J Ophthalmol; 1991 Nov; 75(11):675-9. PubMed ID: 1751464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tobramycin in external eye disease: a double-masked study vs. gentamicin.
    Leibowitz HM; Hyndiuk RA; Smolin GR; Nozik RA; Hunter GJ; Cagle GD; Davis DS
    Curr Eye Res; 1981; 1(5):259-66. PubMed ID: 7030632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twice-a-day versus four-times-a-day ofloxacin treatment of external ocular infection.
    Friedlaender MH
    CLAO J; 1998 Jan; 24(1):48-51. PubMed ID: 9474454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ofloxacin monotherapy for the primary treatment of microbial keratitis: a double-masked, randomized, controlled trial with conventional dual therapy. The Ofloxacin Study Group.
    Ophthalmology; 1997 Nov; 104(11):1902-9. PubMed ID: 9373124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of chronic staphylococcal blepharoconjunctivitis with a new topical steroid anti-infective ophthalmic solution.
    Donshik P; Kulvin SM; Mckinley P; Skowron R
    Ann Ophthalmol; 1983 Feb; 15(2):162-7. PubMed ID: 6340583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of topical 0.3% ofloxacin with fortified tobramycin plus cefazolin in the treatment of bacterial keratitis.
    Panda A; Ahuja R; Sastry SS
    Eye (Lond); 1999 Dec; 13 ( Pt 6)():744-7. PubMed ID: 10707137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ofloxacin vs tobramycin for the treatment of external ocular infection. Ofloxacin Study Group II.
    Gwon A
    Arch Ophthalmol; 1992 Sep; 110(9):1234-7. PubMed ID: 1520109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for treatment outcome of suspected microbial keratitis. Ofloxacin Study Group.
    Morlet N; Minassian D; Butcher J
    Br J Ophthalmol; 1999 Sep; 83(9):1027-31. PubMed ID: 10460769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absorption of topically administered ciprofloxacin, ofloxacin and gentamicin in the inflamed rabbit eye.
    Behrens-Baumann W
    Ophthalmologica; 1996; 210(2):119-22. PubMed ID: 8859488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ciprofloxacin ophthalmic solution versus rifamycin ophthalmic solution for the treatment of conjunctivitis and blepharitis.
    Adenis JP; Colin J; Verin P; Saint-Blancat P; Malet F
    Eur J Ophthalmol; 1995; 5(2):82-7. PubMed ID: 7549447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase III clinical trial of 0.5% levofloxacin ophthalmic solution versus 0.3% ofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis.
    Schwab IR; Friedlaender M; McCulley J; Lichtenstein SJ; Moran CT;
    Ophthalmology; 2003 Mar; 110(3):457-65. PubMed ID: 12623805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of experimental bacterial keratitis with topical trovafloxacin.
    Barequet IS; Denton P; Osterhout GJ; Tuli S; O'Brien TP
    Arch Ophthalmol; 2004 Jan; 122(1):65-9. PubMed ID: 14718297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical investigation of 0.3% levofloxacin eyedrops on the treatment of cases with acute bacterial conjunctivitis and bacterial keratitis].
    Zhang M; Hu Y; Chen F
    Yan Ke Xue Bao; 2000 Jun; 16(2):146-8. PubMed ID: 12579927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-marketing surveillance of levofloxacin 0.5% ophthalmic solution for external ocular infections.
    Kanda Y; Kayama T; Okamoto S; Hashimoto M; Ishida C; Yanai T; Fukumoto M; Kunihiro E
    Drugs R D; 2012 Dec; 12(4):177-85. PubMed ID: 23075336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of moxifloxacin-dexamethasone eyedrops as treatment for bacterial ocular infection associated with bacterial blepharitis.
    Belfort R; Gabriel L; Martins Bispo PJ; Muccioli C; Zacharias Serapicos PC; Clark L; Bell B; Bartell J; Stroman DW; Höfling-Lima AL
    Adv Ther; 2012 May; 29(5):416-26. PubMed ID: 22562783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Distribution of gentamicin in the eye after administration of eye film by various methods].
    Iuzhakov AM
    Antibiot Khimioter; 1991 Feb; 36(2):29-31. PubMed ID: 2025114
    [No Abstract]   [Full Text] [Related]  

  • 19. Topical application of a gentamicin-collagen sponge combined with systemic antibiotic therapy for the treatment of diabetic foot infections of moderate severity: a randomized, controlled, multicenter clinical trial.
    Lipsky BA; Kuss M; Edmonds M; Reyzelman A; Sigal F
    J Am Podiatr Med Assoc; 2012; 102(3):223-32. PubMed ID: 22659765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A review of safety and efficacy of levofloxacin 0.5% ophthalmic solution in the treatment of external ocular infections and in prophylaxis of postoperative endophthalmitis].
    Lazicka-Gałecka M; Gałecki T; Szaflik JP
    Klin Oczna; 2015; 117(2):123-9. PubMed ID: 26638552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.